Long-chain polyunsaturated fatty acids are highly enriched in the nervous system. Docosahexaenoic acid (DHA 2 ; 22:6n-3), in particular, is the most abundant polyunsaturated fatty acid in the brain and is concentrated in aminophospholipids of cell membranes. Numerous studies have indicated that this concentration of DHA in the nervous system is essential for optimal neuronal and retinal functions (1). Although the underlying mechanisms of its essential function are still not clearly understood, emerging evidence suggests that unique metabolism of DHA in relation to its incorporation into neuronal membrane phospholipids plays an important role. In this review, biochemical mechanisms for enriching and metabolizing DHA in neural cells are discussed in the context of their biological significance in neuronal function.
Accretion of DHA in Neural CellsAccretion of docosahexaenoic acid (4,7,10,13,16,19-22:6) in the central nervous system actively occurs during the developmental period, primarily relying on circulating plasma DHA derived from diet or from biosynthesis in the liver (2). However, local biosynthesis of DHA also occurs in the brain, providing an alternative source of DHA for its accumulation in the brain (3). It is well established that DHA can be biosynthesized from ␣-linolenic acid (18:3n-3; 9,12,15-18:3), a shorter chain n-3 fatty acid precursor, through chain elongation and desaturation processes (4) (Fig. 1). Linolenic acid is desaturated to 18:4n-3 (6,9,12,15-18:3) by ⌬6-desaturase, chain-elongated to 20:4n-3 (8,11,14,17-20:4), and subsequently converted to eicosapentaenoic acid (20:5n-3; 5,8,11,14,17-20:5) by ⌬5-desaturase in the endoplasmic reticulum (ER). Mammalian ⌬5-and ⌬6-desaturases have been identified and cloned (5). However, ⌬4-desaturase, responsible for making 22:6n-3 directly from 22:5n-3, an elongation product of 20:5n-3, has been identified only in microalgae (6). In mammals, 22:5n-3 is further elongated to 24:5n-3 (9,12,15,18,21-24:5) followed by desaturation by ⌬6-desaturase to 24:6n-3 (6,9,12,15,18,21-24:6). Subsequently, 24:6n-3 is transferred to peroxisomes and converted to 22:6n-3 by removing two carbon chains by -oxidation. DHA thus formed is transferred back to the ER and quickly incorporated into membrane phospholipids by esterification during de novo synthesis or by a deacylation-reacylation reaction. Because biosynthesis of both fatty acids and phospholipids occurs in ER, a particular fatty acid intermediate can be either incorporated into phospholipids or further chain-elongated/desaturated, although the regulation of these processes is still poorly understood. Long-chain n-6 fatty acids are biosynthesized from linoleic acid (18:2n-6) using the analogous pathway and the same enzyme system. In most tissues, the commonly observed longchain n-6 fatty acid is arachidonic acid (AA) (20:4n-6). Docosapentaenoic acid (22:5n-6, DPAn-6), produced by further elongation and desaturation of AA and subsequent peroxisomal -oxidation, is rather a minor component, and yet it accumulates...